Phase 3 COVID-19 Vaccines – Rev b
image credit: slocounty.ca.gov
- Oct 12, 2020 11:03 pm GMTOct 12, 2020 11:01 pm GMT
- 310 views
What the original post of this document attempted to do is define firms and partnerships that had entered Phase 3 trials for their COVID-19 vaccines as its posting date (July 31). In Rev a, I attempted to describe all developers that will likely offer vaccines in the U.S. in large volumes before the end of 2020 or early 2021. I drew new developers from additional firms that signed “The Pledge” (see section 3 below).
In Rev b, I believe that at least the top three vaccine candidates’ manufacturers (Moderna mRNA-1273, Pfizer / BioNTech BNT162b2 and Oxford / AstraZeneca's AZD-1222) and other stake-holders are starting to form a reasonable estimate of when the vaccines’ trials might show any positive results, and how they might be allocated when released. I’ve added this additional information while retaining content from Rev a.